Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer.

@article{Ahmad2004PololikeK,
  title={Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer.},
  author={Nihal Ahmad},
  journal={FASEB journal : official publication of the Federation of American Societies for Experimental Biology},
  year={2004},
  volume={18 1},
  pages={5-7}
}
  • Nihal Ahmad
  • Published 2004 in
    FASEB journal : official publication of the…
Second only to skin cancer, cancer of the prostate gland (CaP) is the most commonly occurring cancer in American men. Existing treatment approaches and surgical intervention have been unable to effectively manage this dreaded cancer; therefore, efforts are ongoing to explore novel targets and strategies for the management of CaP. A complete understanding of the genetic control of the processes of cellular proliferation and programmed cell death, or "apoptosis," may provide the basis for the… CONTINUE READING